AbbVie has lost a legal challenge seeking to block a Mississippi law that requires it to provide discounted medicines to some ...

An accompanying study of the high dose in adults with a BMI of 30 or more and type 2 diabetes, STEP UP T2D, has also been ...

To address these challenges, there is a growing focus on rethinking chronic wound management, with particular emphasis on ...

Swedish biotech Camurus is reportedly in talks to acquire its US partner Braeburn Pharma in a deal that would give it full control of their product for treating opioid use disorder (OUD).

Eli Lilly, meanwhile, also revealed that it had paused work on its Gateway Labs biotech incubator – part of a £279 million ...

With the much-anticipated release today of the Make America Healthy Again report and strategy document, the US Department of ...

Danish GLP-1 giant Novo Nordisk announced a restructuring effort today that will cut 9,000 jobs, a little over 11% of its ...

The top-ranked trust in England is Moorfields Eye Hospital NHS Foundation Trust, followed by the Royal National Orthopaedic ...

MSD is scrapping a £1 billion ($1.35 billion) expansion of its UK operations – including a facility already under ...

The UK government is reported to be trying to restart talks over drug pricing and rebates after MSD's shock decision to scrap ...

The Series 11 Apple Watch can spot signs of chronic high blood pressure and warn users that they may have hypertension, ...

The case dates back to 2014, when Ronald Streck, a former executive at a network of regional drug wholesalers, failed a ...